Discovery Life Sciences: Albert Li

Dec 02, 2021

Albert Li will join Discovery Life Sciences as CSO of pharmacology and toxicology as part of the firm's recent acquisition of In Vitro ADMET Laboratories (IVAL). Li, who founded IVAL in 2004, has been pioneering the isolation, cryopreservation, and culturing of human hepatocytes and their use in evaluating drug metabolism, drug-drug interactions, and drug toxicity.

Breaking News

Top Five Articles on GenomeWeb Last Week: 10x Genomics EU Lawsuits, Castle Bio Noncoverage, More
Large Study of Early-Onset Colorectal Cancer Patients IDs Unique, Potentially Actionable Mutations
New Primate Genomes Study Deepens Understanding of Humans
People in the News at Illumina, Pacific Biosciences, Myriad Genetics, Delfi Diagnostics, More
New Products Posted to GenomeWeb: LabCorp, BostonGene, Seer, Myriad Genetics, More

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.